Novo Nordisk
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.About NVO
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments.
NVO Key Statistics
NVO News
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NVO -2.90%),...
On Friday, Novo Nordisk A/S NVO announced interim results from the phase 3 FRONTIER3 trial of 70 children (aged 1-11 years old) with hemophilia A with and witho...
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite missing the company’s initial sales expec...
Analyst ratings
71%
of 34 ratingsMore NVO News
JPMorgan lowered the firm’s price target on Novo Nordisk (NVO) to DKK 1,000 from DKK 1,050 and keeps an Overweight rating on the shares. Maximize Your Portfoli...
For Eli Lilly and Novo Nordisk, the present and future are about weight loss drugs. The two companies dominate the market for GLP-1 drugs, which are prescribed...
A pharma industry group is urging the U.S. Food and Drug Administration (FDA) to block what it calls a “dangerous” Super Bowl ad from the digital healthcare com...
Sales of Eli Lilly’s (LLY0.00% ) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s initial sales expectations....
Maximize Your Portfolio with Data Driven Insights: Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks an...
...
Novo Nordisk A/S NVO announced that its weight-loss drug Wegovy has reached 1.2 million U.S. patients. Of these, 55 million individuals are covered by insurance...
